(Q33825182)

English

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Green LL

1

1 reference

Europe PubMed Central

29 July 2017

publication date

1 December 1999

1 reference

Europe PubMed Central

29 July 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

29 July 2017

231

1 reference

Europe PubMed Central

29 July 2017

1-2

1 reference

Europe PubMed Central

29 July 2017

11-23

1 reference

Europe PubMed Central

29 July 2017

Anaphylactic shock after retreatment with OKT3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Engineering Antibodies for Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Preparation of clone libraries in yeast artificial-chromosome vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

A directory of human germ-line V kappa segments reveals a strong bias in their usage

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Germ-line transmission and expression of a human-derived yeast artificial chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Use of rituximab, the new FDA-approved antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Ten years of Orthoclone OKT3 (muromonab-CD3): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Humanized monoclonal antibody for prevention of respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Inactivation of the mouse HPRT locus by a 203-bp retroposon insertion and a 55-kb gene-targeted deletion: establishment of new HPRT-deficient mouse embryonic stem cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Human antibodies by design.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

The use of antibodies against the IL-2 receptor in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

The pharmacology of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Man-made antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Immunologic and pharmacologic concepts of monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

Organization of the human immunoglobulin heavy-chain locus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900137-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-1759(99)00137-4

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33825182&oldid=1947734414"